Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $54.51 million. The enterprise value is $69.53 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 92.49 million shares outstanding. The number of shares has increased by 38.28% in one year.
| Current Share Class | 92.49M |
| Shares Outstanding | 92.49M |
| Shares Change (YoY) | +38.28% |
| Shares Change (QoQ) | +40.86% |
| Owned by Insiders (%) | 61.61% |
| Owned by Institutions (%) | 13.18% |
| Float | 17.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.29 |
| Forward PS | 3.00 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 1.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.87 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -62.87% |
| Return on Invested Capital (ROIC) | -94.99% |
| Return on Capital Employed (ROCE) | -426.91% |
| Revenue Per Employee | $101,113 |
| Profits Per Employee | -$929,437 |
| Employee Count | 71 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 4.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.91% in the last 52 weeks. The beta is 1.76, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | -92.91% |
| 50-Day Moving Average | 0.51 |
| 200-Day Moving Average | 0.98 |
| Relative Strength Index (RSI) | 55.51 |
| Average Volume (20 Days) | 266,798 |
Short Selling Information
The latest short interest is 3.15 million, so 3.41% of the outstanding shares have been sold short.
| Short Interest | 3.15M |
| Short Previous Month | 2.71M |
| Short % of Shares Out | 3.41% |
| Short % of Float | 18.25% |
| Short Ratio (days to cover) | 12.22 |
Income Statement
In the last 12 months, VRCA had revenue of $7.18 million and -$65.99 million in losses. Loss per share was -$1.03.
| Revenue | 7.18M |
| Gross Profit | -4.04M |
| Operating Income | -54.57M |
| Pretax Income | -80.74M |
| Net Income | -65.99M |
| EBITDA | -53.73M |
| EBIT | -54.57M |
| Loss Per Share | -$1.03 |
Full Income StatementBalance Sheet
The company has $29.60 million in cash and $42.43 million in debt, giving a net cash position of -$12.84 million or -$0.14 per share.
| Cash & Cash Equivalents | 29.60M |
| Total Debt | 42.43M |
| Net Cash | -12.84M |
| Net Cash Per Share | -$0.14 |
| Equity (Book Value) | -18.58M |
| Book Value Per Share | -0.20 |
| Working Capital | 10.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$53.66 million and capital expenditures -$27,000, giving a free cash flow of -$53.68 million.
| Operating Cash Flow | -53.66M |
| Capital Expenditures | -27,000 |
| Free Cash Flow | -53.68M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
| Gross Margin | -56.22% |
| Operating Margin | -760.09% |
| Pretax Margin | -919.21% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.28% |
| Shareholder Yield | -38.28% |
| Earnings Yield | -116.41% |
| FCF Yield | -94.70% |
Analyst Forecast
The average price target for VRCA is $6.00, which is 917.98% higher than the current price. The consensus rating is "Hold".
| Price Target | $6.00 |
| Price Target Difference | 917.98% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 105.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VRCA has an Altman Z-Score of -12.73 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.73 |
| Piotroski F-Score | 4 |